Filing Details
- Accession Number:
- 0001209191-20-060365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-24 19:15:18
- Reporting Period:
- 2020-11-20
- Accepted Time:
- 2020-11-24 19:15:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180262 | Herbalife Nutrition Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1343530 | John Tartol | 800 W. Olympic Blvd. Suite 406 Los Angeles CA 90015 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-20 | 9,052 | $39.79 | 369,938 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-20 | 7,479 | $48.16 | 362,459 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-11-23 | 55,000 | $48.83 | 307,459 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-24 | 1,573 | $48.35 | 305,886 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2020-11-20 | 9,052 | $0.00 | 9,052 | $39.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-04-15 | 2020-12-19 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $48.65 to $49.05. The price reported reflects the weighted average sale price of $48.83. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering4,526 shares at an exercise price of $79.58 per share.
- The SARs were granted on December 19, 2013. 50% vested on December 19, 2013, 25% vested on January 15, 2014 and the remaining 25% vested on April 15, 2014.
Billionaire Hedge Funds
